Top Markets
Coin of the day
Genix Pharmaceuticals Corporation Genix Pharmaceuticals Corporation

Genix Pharmaceuticals Corporation

GENPF
Pozycja w akcjach #38708
Genix Pharmaceuticals Corporation, established in 1993 and headquartered in... Genix Pharmaceuticals Corporation, established in 1993 and headquartered in Vancouver, Canada, is actively involved in the creation, production, licensing, and distribution of various life science products. The company's primary focus in the Canadian market is on nutraceuticals and pharmaceuticals. Their product pipeline features several key developments: Flu-X: An herbal treatment available as an oral solution or spray, targeting viral infections, influenza, and coronaviruses responsible for common colds. Renochlor: A nutritional supplement formulated to support the revitalization and maintenance of kidney health and function. Sucanon: An insulin sensitizer designed to reduce blood sugar by improving the sensitivity of muscle, fat, and liver cells to insulin. Beyond these, Genix Pharmaceuticals also offers a wide range of other nutraceuticals and pharmaceutical items. This selection includes supplements such as bee propolis capsules, liquid calcium softgels, seal oil softgels, marine lipid softgels, lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, alongside ophthalmic products like eye ointments and drops. The company operated under the name Alta Natural Herbs & Supplements Ltd. until it adopted its current identity, Genix Pharmaceuticals Corporation, in June 2019.
Cena akcji
$0.0138
Ostatnia synchronizacja: 2026-08-13
Kapitalizacja rynkowa
$844.89K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
CA
Handel Genix Pharmaceuticals Corporation (GENPF)

Kategoria

Cena GENPF z kapitalizacją rynkową B
Genix Pharmaceuticals Corporation Genix Pharmaceuticals Corporation
GENPF
$0.0138
Kapitalizacja rynkowa Genix Pharmaceuticals Corporation(GENPF)
Kapitalizacja rynkowa: $844.89K
Na dzień August 2026 spółka Genix Pharmaceuticals Corporation ma kapitalizację rynkową wynoszącą $844.89K. Według naszych danych, czyni to Genix Pharmaceuticals Corporation 38708th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Genix Pharmaceuticals Corporation od 2020 do 2026
GENPF w porównaniu do 5 najpopularniejszych stocks
Cena za GENPF Aktywa B Kapitalizacja rynkowa B Wyniki
Genix Pharmaceuticals Corporation Genix Pharmaceuticals Corporation
$89,467.65 $844.89K
$5.478T +648,316,218.03%
Genix Pharmaceuticals Corporation Genix Pharmaceuticals Corporation
$73,308.28 $844.89K
$4.488T +531,219,307.62%
Genix Pharmaceuticals Corporation Genix Pharmaceuticals Corporation
$68,003.65 $844.89K
$4.163T +492,779,942.42%
Genix Pharmaceuticals Corporation Genix Pharmaceuticals Corporation
$60,506.51 $844.89K
$3.704T +438,452,865.09%
Genix Pharmaceuticals Corporation Genix Pharmaceuticals Corporation
$46,411.24 $844.89K
$2.841T +336,313,253.90%